RECENT NEWS

Mid and South Essex NHS Foundation Trust has signed a 15-year contract with private laboratory services provider SYNLAB, for the delivery of a unified pathology service.

The British people, the NHS and the economy will be better protected against future global health threats thanks to a new World Health Organization Pandemic Agreement adopted by the UK.

UKHSA data shows the influenza vaccine prevented 96,000 to 120,200 hospitalisations in England during last winter.

Anatomic and forensic pathology equipment firm Mopec Group has announced a strategic partnership with Lumea, an innovator in digital pathology and AI-powered workflows.

Neurogen Biomarking and Aranscia, a provider of clinical workflow and diagnostic technology, have announced a partnership in which Aranscia's technical and laboratory resources will help to deliver clinical insights and HIPAA-compliant connectivity for the Neurogen Biomarking ecosystem.

SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a new rapid diagnostic testing tool to detect respiratory syncytial virus (RSV) in professional healthcare settings.

Entries are now open for the Lab Awards, which provides a platform to formally recognise the achievements of the laboratory community across the UK and Ireland.

Roche has announced a strategic collaboration with Broad Clinical Labs to develop and pilot groundbreaking applications using Roche’s recently unveiled next-generation sequencing (NGS) Sequencing By Expansion (SBX) technology.

Barts Health NHS Trust has become the first healthcare provider in the NHS to implement Anonymise and Export from medical imaging IT company Sectra, with large volumes of anonymised diagnostic images available to aid ground-breaking research and medical innovations.

New research from University of Illinois Urbana-Champaign food scientists suggests certain nanoplastics may make foodborne pathogens more virulent.

A review funded as part of Genomics England’s Diverse Data initiative and led by UCL researchers has outlined how the analytical methods used to process and interpret genomic data play a critical role in promoting health equity.

A new study published by health and care charity The King’s Fund uncovers the tough decisions NHS leaders are making to balance their books and protect patient care.

Revvity has announced the launch of its new IDS i20 analytical random access platform from EUROIMMUN, enabling full automation of chemiluminescence immunoassays (ChLIA).

Fujirebio has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse G plasma ratio in vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline.

Life sciences and diagnostics firm Revvity, has chosen Bruntwood SciTech’s Alderley Park as its newest UK hub.

North Bristol NHS Trust and Fujifilm Healthcare Europe are to continue their long-standing relationship, with the establishment of a reference site agreement for the UK featuring the Synapse Pathology solution to support Bristol’s innovative histology practice.

Researchers at Amsterdam University Medical Center (UMC) have taken a big step towards a vaccine for HIV after its first in-human assessment of germline-targeting strategy with a trimer displays positive results.

The Microbiology Society, together with the British Mycological Society, has announced Dr Harry Chown of Imperial College London, UK, as the winner of the 2025 Tony Trinci Award.

Becton Dickinson (BD) has announced the global commercial launch of the world's first cell analyser featuring breakthrough spectral and real-time cell imaging technologies.

A research team at the Korea Institute of Machinery and Materials (KIMM) has developed a compact, rapid pretreatment system capable of liquefying and homogenising solid biological samples in under one minute.